Back Stocks profile

Stock analysis tool for investors

Procter & Gamble Health Ltd.

NSE: PGHL | BSE:500126

₹5107.40 16.35 (0.32%) 1D

Pharmaceuticals & Biotechnology

Open an Account with Bigul in 5 minutes

Performance

Today’s low

5062.20

Today’s High

5140.00

52W low

4492.80

52W High

5642.80

Open Price

5092.00

Prev. Close

5091.0500

Volume

8066.00

Value

41196288.40

Fundamentals

Market Cap Cr

8478.00

Price to Earnings

37.40

Price to Book Value

11.30

Dividend Yield

4.90

PE to Growth

-14.10

Op Revenue TTM Cr

1237.00

Net Profit TTM Cr

226.65

Cash From Operating Activity Cr

236.00

Return on Equity %

30.55

EMA & SMA

Bullish Moving Averages

4

Bearish Moving Averages

12

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

01 Mar, 2024

50

Week

69.1

Month

67.9

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

5103.22

PIVOT

First Resistance

5144.18

Second Resistance

5180.97

Third Resistance

5221.93

First Support

5066.43

Second Support

5025.47

Third Support

4988.68

Relative Strength Index

45.53

Money Flow Index

41.97

MACD

-33.89

MACD Signal

-18.78

Average True Range

110.02

Average Directional Index

17.17

Rate of Change (21)

-1.23

Rate of Change (125)

4.77

Commodity Channel Index

-46.2

Williams %R

-83.9

BETA

1 Month

-0.53

3 Month

-0.1

1 Year

0.27

3 Year

0.15

PRICE CHANGE ANALYSIS

0.7%

1 Week

Low

High

5044

5147.3

-1.23%

1 Month

Low

High

5010

5642.85

-0.41%

3 Months

Low

High

4905.75

5642.85

5.57%

6 Months

Low

High

4825.05

5642.85

4.53%

1 Year

Low

High

4492.8

5642.85

Bigul
27 Feb 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, We hereby inform you regarding issuance of duplicate share certificate, as detailed in enclosed letter. Kindly take note of the same.
Bigul
27 Feb 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, We have been informed by our shareholder regarding loss of share certificate, as detailed in enclosed letter. Request you to kindly take note of the same.
Bigul
06 Feb 2024

Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Dividend Updates

Find enclosed communication with respect to deduction of tax on dividend income declared by the Company.
Bigul
06 Feb 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Find enclosed details with respect to loss of share certificate(s) of shareholder(s) of the Company as intimated by the Company''s RTA, Kfin Technologies Limited.
Bigul
06 Feb 2024

Q2FY24 Quarterly Result Announced for Procter & Gamble Health Ltd.

Pharmaceuticals company Procter & Gamble Health announced Q2FY24 results: In a challenging operating environment, the company reported sales of Rs 304 crore, at par vs a year ago. The Profit After Tax (PAT) for the quarter was Rs 72 crore, down 6% vs year ago, owing to one-time items in the quarter. Excluding this one-time impact, Profit After Tax (PAT) was up by 2% vs a year ago. Milind Thatte, Managing Director, P&G; Health India, said, “This has been a challenging quarter for the Company on account of an overall slowdown in the Vitamins, Minerals and Supplements category coupled with a delayed seasonal onset. The team continued to stay resilient. With improved productivity, efficiency and continued strategic investments, we have been able to deliver a modest topline and bottom-line. We remain committed to our integrated growth strategy of a focused product portfolio, superiority, productivity, constructive disruption, and an agile and accountable organization structure. We are confident that this strategy combined with our operational agility will help us navigate the mid-term and deliver balanced growth.” Result PDF
Bigul
06 Feb 2024

Procter & Gamble Health Ltd - 500126 - Press Release On Unaudited Financial Results For Quarter Ended December 31, 2023

We are enclosing herewith the press release regarding the unaudited financial results for the Quarter ended December 31, 2024, approved by the Board at its meeting held today.
Bigul
06 Feb 2024

Procter & Gamble Health Ltd - 500126 - Corporate Action-Board approves Dividend

Board has approved interim dividend for Financial Year 2023-24 at its meeting held today. Please find enclosed details regarding record date and payout of said dividend.
Bigul
06 Feb 2024

Procter & Gamble Health Ltd - 500126 - Unaudited Financial Results For The Quarter Ended December 31, 2023

We are pleased to inform you that at a meeting of Board of Directors held today, the Unaudited Financial results for the quarter ended December 31, 2023 were approved by the Board. Same are enclosed for your perusal, along with Limited review report furnished by the statutory auditors of the Company.
Bigul
06 Feb 2024

Procter & Gamble Health Ltd - 500126 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended December 31, 2023 And Interim Dividend For Financial Year 2023-24

We are pleased to inform you that at a meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended December 31, 2023 were approved. Further, we are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have declared an Interim Dividend for the Financial Year 2023-24 of Rs. 200 (including one-time special dividend of Rs. 150) per Equity Share having face value of Rs. 10/- each. The dividend shall be paid on or before March 3, 2024.
Bigul
31 Jan 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, Please find attached disclosure regarding issuance of duplicate share certificate. Request you to kindly take the same on record.
See all News

FAQs

The latest market price of Procter & Gamble Health Ltd. on NSE was Rs. 5107.40 as of today.

The opening share price of Procter & Gamble Health Ltd. was Rs. 5092.00 as of today.

The 52-week high share price of Procter & Gamble Health Ltd. was Rs. 5642.80.

The 52 week low share price of Procter & Gamble Health Ltd. was Rs. 4492.80.

Procter & Gamble Health Ltd. has a market cap of Rs. 8478.00 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Procter & Gamble Health Ltd. is -14.10. Please refer to the Fundamentals section for further details.

The operating revenue for Procter & Gamble Health Ltd. in the last FY was Rs.  1237.00 crore. Please refer to the Financials section for further details.

The Net Profit for Procter & Gamble Health Ltd. in the last FY was Rs. 226.65 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Procter & Gamble Health Ltd. was on 2024-02-14 for Rs. 150 per share. According to today’s share price, the dividend yield of Procter & Gamble Health Ltd. stands at 4.90. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Procter & Gamble Health Ltd..